Congenital Peripheral Primitive Neuroectodermal Tumor (pPNET)/Ewing's Sarcoma of the Upper Limb in a Neonate: A Rare Case Report

Authors

  • Bharti Sharma Department of Pathology, Pt. B D Sharma PGIMS, Rohtak, Haryana, India
  • Ritesh K Sheorain Department of Pathology, Pt. B D Sharma PGIMS, Rohtak, Haryana, India

DOI:

https://doi.org/10.55489/njmr.160420261365

Keywords:

Upper Extremity, Neuroectodermal tumor, Ewing Sarcoma, Newborn, Soft Tissue Neoplasms, Case Report

Abstract

Background: Ewing’s sarcoma (EWS)/peripheral primitive neuroectodermal tumor (pPNET) is a rare, aggressive small‑round‑cell malignancy primarily of children and adolescents; congenital presentations are exceptional. We report a neonate with congenital pPNET of the arm.

Case presentation: A 24‑day‑old full‑term female presented with a progressively enlarging left‑arm swelling present since birth. Birth and maternal histories were unremarkable; no family history of genetic disease.

Clinical findings: Examination revealed a 6 × 6 cm soft, immobile posterolateral arm mass. Laboratory values were within normal limits.

Diagnostic assessment: Ultrasound showed a hypoechoic lobulated intermuscular lesion. MRI demonstrated a well‑circumscribed T1 hypointense, T2/STIR hyperintense ovoid mass abutting but not invading adjacent structures. FNAC revealed sheets of small round blue cells. Excisional biopsy showed uniform small round cells; immunohistochemistry was CD99 and vimentin positive, desmin, myogenin, synaptophysin, S‑100, EMA, and LCA negative. Cytogenetic/molecular testing was not performed due to resource constraints.

Therapeutic intervention: Radical surgical resection followed by four cycles of cisplatin and cyclophosphamide at 3‑week intervals.

Follow‑up and outcomes: Immediate postoperative imaging showed no metastasis; postoperative course was uneventful. Patient lost to follow‑up after three months.

Conclusion: Congenital pPNET/EWS is extremely rare and aggressive. Diagnosis relies on histopathology and IHC when molecular tests are unavailable. Early recognition and multimodal therapy are critical, but prognosis in neonates remains guarded.

References

1. Kocjan G. Diagnostic dilemmas in FNAC cytology: small round cell tumors. In: Kocjan G, editor. Fine needle aspiration cytology: diagnostic principles and dilemmas. Berlin: Springer-Verlag; 2006. p.133-4.

2. Okpokowuruk FS, Oloyede I. Congenital Ewing's Sarcoma in a neonate in Uyo - a case report. Pan Afr Med J. 2013;15:90. DOI: https://doi.org/10.11604/pamj.2013.15.90.2219 PMid:24198886 PMCid:PMC3810286

3. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer. 2009 Aug 1;115(15):3526-3536. DOI: https://doi.org/10.1002/cncr.24388 PMid:19548262

4. Jin SG, Jiang XP, Zhong L. Congenital Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: A Case Report and Review of the Literature. Pediatr Neonatol. 2016 Oct;57(5):436-439. DOI: https://doi.org/10.1016/j.pedneo.2013.11.002 PMid:24480101

5. Teicher BA, Bagley RG, Rouleau C, Kruger A, Ren Y, Kurtzberg L. Characteristics of human Ewing/PNET sarcoma models. Ann Saudi Med. 2011;31(2):174-182. DOI: https://doi.org/10.4103/0256-4947.78206 PMid:21422656 PMCid:PMC3102479

6. Ewing J. Classics in oncology. Diffuse endothelioma of bone. James Ewing. Proceedings of the New York Pathological society, 1921. CA Cancer J Clin. 1972; 22(2):95-98. DOI: https://doi.org/10.3322/canjclin.22.2.95 PMid:4622125

7. Shrateh ON, Jobran AW, Owienah H, Sweileh T, Abulihya M, Natsheh MA, et al. Primary extraskeletal Ewing sarcoma of the foot with extensive skeletal and pulmonary metastasis: a rare case report. Ann Med Surg (Lond). 2022;82:104752. DOI: https://doi.org/10.1016/j.amsu.2022.104752 PMid:36268294 PMCid:PMC9577863

8. Abboud A, Masrouha K, Saliba M, Haidar R, Saab R, Khoury N, et al. Extraskeletal Ewing sarcoma: diagnosis, management and prognosis. Oncol Lett. 2021;21(5):354. DOI: https://doi.org/10.3892/ol.2021.12615 PMid:33747211 PMCid:PMC7967932

9. Vasileva E, Arata C, Luo Y, Burgos R, Crump JG, Amatruda JF. Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm. Cell Rep. 2025 Oct 28;44(10):116376. DOI: https://doi.org/10.1016/j.celrep.2025.116376 PMid:41072418

10. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2020. (World Health Organization classification of tumours, volume 3).

11. Vural C, Uluoglu O, Akyurek N, Oguz A, Karadeniz C.The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors. Pathol Oncol Res. 2011;17(3):619-625. DOI: https://doi.org/10.1007/s12253-010-9358-3 PMid:21267687

12. Marec-Bérard P, Chotel F, Claude L. PNET/Ewing tumours: current treatments and future perspectives. Bull Cancer. 2010 Jun;97(6):707-713. DOI: https://doi.org/10.1684/bdc.2010.1120 PMID: 20497910

13. Veal GJ, Errington J, Sastry J, Chisholm J, Brock P, Morgenstern D, et al. Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer Chemother Pharmacol. 2016 Apr;77(4):685-692. DOI: https://doi.org/10.1007/s00280-016-2975-0 PMid:26875154 PMCid:PMC4819938

Downloads

Published

2026-10-01

How to Cite

Sharma, B., & Sheorain, R. K. (2026). Congenital Peripheral Primitive Neuroectodermal Tumor (pPNET)/Ewing’s Sarcoma of the Upper Limb in a Neonate: A Rare Case Report. National Journal of Medical Research, 16(04), 322–326. https://doi.org/10.55489/njmr.160420261365

Issue

Section

Case Report